Expedition Therapeutics
San Diego, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $165M
Overview
Using human genetics to discover small-molecule drugs for neuroscience and rare disorders.
NeuroscienceRare Disease
Technology Platform
A genetics-driven, phenotypic discovery platform that uses human genetic data to guide functional screens for small-molecule therapeutics.
Funding History
1Total raised:$165M
Series A$165M
Opportunities
Potential to discover first-in-class mechanisms for devastating neurological and rare diseases with genetic validation.
Risk Factors
High risk of failure inherent in novel CNS target discovery and the long development timelines.
Competitive Landscape
Operates in the crowded but high-need neuroscience field, competing with other genetics-focused discovery companies.